Edgewise Therapeutics, Inc. (EWTX)

30.91 +0.82 (+2.73%) USD  |  NASDAQ  |  Feb 24, 16:00
31.00 +0.09 (+0.29%) After-Hours: 20:00
More

Edgewise Therapeutics Change in Payables and Accrued Expense (Quarterly)

Change in Payables and Accrued Expense (Quarterly) Chart

View Change in Payables and Accrued Expense (Quarterly) for EWTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Payables and Accrued Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

View Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Payables and Accrued Expense (Quarterly) Benchmarks

View Change in Payables and Accrued Expense (Quarterly) Benchmarks
Start Trial
Glaukos Corp. Upgrade
Nuvalent, Inc. Upgrade
Neurocrine Biosciences, Inc. Upgrade
Dynavax Technologies Corp. (DELISTED) Upgrade
Omeros Corp. Upgrade